H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 103 Citations 36,478 684 World Ranking 3317 National Ranking 38

Research.com Recognitions

Awards & Achievements

2020 - Member of Academia Europaea

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Virus

Peter Aaby focuses on Pediatrics, Immunology, Vaccination, Measles and Measles vaccine. His Pediatrics research includes elements of Epidemiology, Mortality rate, Randomized controlled trial, Child mortality and Infant mortality. His research integrates issues of Internal medicine, Incidence, Cohort study and Tuberculosis in his study of Immunology.

Peter Aaby has researched Vaccination in several fields, including Tuberculosis vaccines, Heterologous and Immunization. His Measles research includes elements of Viral disease, Case fatality rate, Vaccine efficacy and Serology. Peter Aaby usually deals with Measles vaccine and limits it to topics linked to Standardized mortality ratio and Cause of death.

His most cited work include:

  • The Danish National Birth Cohort - its background, structure and aim: (812 citations)
  • Measles and atopy in Guinea-Bissau (529 citations)
  • A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. (397 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Pediatrics, Vaccination, Immunology, Measles and Measles vaccine. The various areas that Peter Aaby examines in his Pediatrics study include Epidemiology, Mortality rate, Randomized controlled trial, Child mortality and Infant mortality. His work in the fields of BCG vaccine, Tetanus and Diphtheria overlaps with other areas such as Guinea bissau.

His Immunology research is multidisciplinary, incorporating perspectives in Internal medicine, Incidence, Cohort study and Tuberculosis. His study in Measles is interdisciplinary in nature, drawing from both Viral disease, Case fatality rate and Vaccine efficacy. His Measles vaccine research is multidisciplinary, relying on both Poliomyelitis, Standardized mortality ratio and Hazard ratio.

He most often published in these fields:

  • Pediatrics (62.68%)
  • Vaccination (56.11%)
  • Immunology (36.79%)

What were the highlights of his more recent work (between 2018-2021)?

  • Vaccination (56.11%)
  • Pediatrics (62.68%)
  • Measles vaccine (34.43%)

In recent papers he was focusing on the following fields of study:

Peter Aaby mostly deals with Vaccination, Pediatrics, Measles vaccine, Measles and Mortality rate. His Vaccination study incorporates themes from Internal medicine, Randomized controlled trial, Proportional hazards model and Tuberculosis. His Pediatrics study combines topics in areas such as Lower mortality, Diphtheria, Tetanus, Public health and Prospective cohort study.

His Measles vaccine research integrates issues from Diphtheria tetanus pertussis, Poliomyelitis and Child mortality. His work deals with themes such as Psychological intervention, Attenuated vaccine and Clinical trial, which intersect with Measles. His BCG vaccine research is classified as research in Immunology.

Between 2018 and 2021, his most popular works were:

  • Outcomes of controlled human malaria infection after BCG vaccination. (57 citations)
  • The COVID-19 pandemic: diverse contexts; different epidemics-how and why? (39 citations)
  • Can existing live vaccines prevent COVID-19? (39 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Virus

Peter Aaby focuses on Vaccination, Randomized controlled trial, Measles, Tuberculosis and Pediatrics. His Vaccination research is under the purview of Immunology. His Randomized controlled trial research is multidisciplinary, incorporating elements of Odds ratio and Confidence interval.

His study in Measles focuses on Measles vaccine in particular. As a member of one scientific family, he mostly works in the field of Tuberculosis, focusing on Observational study and, on occasion, Rabies, Intensive care medicine and Clinical trial. His research ties Public health and Pediatrics together.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

The Danish National Birth Cohort - its background, structure and aim:

Jørn Olsen;Mads Melbye;Sjurdur Frodi Olsen;Thorkild I.A. Sørensen.
Scandinavian Journal of Public Health (2001)

976 Citations

Measles and atopy in Guinea-Bissau

S.O Shaheen;D.J.P Barker;C.B Heyes;A.W Shiell.
The Lancet (1996)

812 Citations

BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity

Rob J.W. Arts;Simone J.C.F.M. Moorlag;Boris Novakovic;Yang Li.
Cell Host & Microbe (2018)

513 Citations

Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.

Christian Wejse;Victor F. Gomes;Paulo Rabna;Per Gustafson.
American Journal of Respiratory and Critical Care Medicine (2009)

496 Citations

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.

Chiea C Khor;Stephen J Chapman;Stephen J Chapman;Fredrik O Vannberg;Aisling Dunne.
Nature Genetics (2007)

494 Citations

Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa

Ines Kristensen;Peter Aaby;Henrik Jensen.
BMJ (2000)

483 Citations

Newborns Develop a Th1-Type Immune Response to Mycobacterium bovis Bacillus Calmette-Guérin Vaccination

Arnaud Marchant;Tessa Goetghebuer;Martin O. Ota;Ingrid Wolfe.
Journal of Immunology (1999)

475 Citations

Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?

Peter Aaby;Adam Roth;Adam Roth;Henrik Ravn;Bitiguida Mutna Napirna.
The Journal of Infectious Diseases (2011)

422 Citations

A small jab – a big effect: nonspecific immunomodulation by vaccines

Christine S. Benn;Mihai G. Netea;Liisa K. Selin;Peter Aaby.
Trends in Immunology (2013)

372 Citations

Influence of Mycobacterium bovis Bacillus Calmette-Guérin on Antibody and Cytokine Responses to Human Neonatal Vaccination

Martin O. C. Ota;Johan Vekemans;Susanna E. Schlegel-Haueter;Katherine Fielding.
Journal of Immunology (2002)

363 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Peter Aaby

Jørn Olsen

Jørn Olsen

Aarhus University Hospital

Publications: 241

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 215

Sjurdur F. Olsen

Sjurdur F. Olsen

Statens Serum Institut

Publications: 109

Mads Melbye

Mads Melbye

University of Copenhagen

Publications: 85

Leo A. B. Joosten

Leo A. B. Joosten

Radboud University Nijmegen

Publications: 81

Christine Stabell Benn

Christine Stabell Benn

University of Southern Denmark

Publications: 76

Hilton Whittle

Hilton Whittle

University of London

Publications: 73

Sarah Rowland-Jones

Sarah Rowland-Jones

University of Sheffield

Publications: 71

Ofer Levy

Ofer Levy

Boston Children's Hospital

Publications: 57

Zulfiqar A Bhutta

Zulfiqar A Bhutta

Aga Khan University

Publications: 56

Thorkild I. A. Sørensen

Thorkild I. A. Sørensen

University of Copenhagen

Publications: 54

Nigel Curtis

Nigel Curtis

Royal Children's Hospital

Publications: 50

Tine Brink Henriksen

Tine Brink Henriksen

Aarhus University Hospital

Publications: 48

Alberto Mantovani

Alberto Mantovani

Humanitas University

Publications: 41

Reinout van Crevel

Reinout van Crevel

Radboud University Nijmegen

Publications: 39

Something went wrong. Please try again later.